Exocan Healthcare Technologies proudly accepted the ‘Innovation Recognition in Aesthetic Device Kit’ for Platexogen at the Aesthetic Medicine India Brand Showcase 2025. The company received the award on June 9th during the Aesthetic Medicine India Conference & Exhibition 2025 at the Bombay Exhibition Centre, Mumbai.
What is Platexogen?
Platexogen is a trademarked autologous exosome product developed by Exocan, specifically engineered for anti-ageing and regenerative treatments. Platexogen stands out because it uses material derived from the patient’s own body. This personalised, autologous therapy offers high biocompatibility and minimal risk of rejection or side effects.
The product is used across various aesthetic applications, including:
- Skin rejuvenation through serums, creams, and facial masks.
- Hair restoration via exosome-based therapies targeting scalp health and hair regrowth.
- Anti-ageing treatments aimed at reducing fine lines, improving skin texture, and promoting collagen regeneration.
Backed by innovation and clinical research
Exocan developed Platexogen using its patented, scalable exosome platform designed for targeted cellular delivery and regenerative applications. Exocan explores the use of exosomes in liquid biopsy and cancer therapy. This work reflects its mission to pioneer exosome science across medical and aesthetic fields.
Clinically validated for safety and efficacy
In collaboration with AKS Clinic, Platexogen-based therapies undergo a rigorous three-stage validation process to ensure safety, scientific integrity, and measurable patient outcomes. This commitment to evidence-based practice is critical in the rapidly evolving field of regenerative aesthetics.
Redefining regenerative aesthetic medicine
Platexogen securing the “Innovation Recognition in Aesthetic Device Kit” recognition at the Aesthetic Medicine India Conference and Exhibition 2025 positions it as a leader in regenerative skin and hair solutions in India. More importantly, it marks a significant milestone in Exocan’s mission to bridge cutting-edge science with real-world clinical outcomes.
Platexogen represents next-gen, patient-specific innovation as regenerative medicine and science reshape modern aesthetic care—driven by the power of exosomes.